Recent Advances in Muscle Relaxants [Abridged]

Recent Advances in Hemophilia Gene Therapy

Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...

Use of muscle relaxants.

The Muscle Relaxants in Anaesthesia

ORIGINAL ARTICLES Leprosy and Childhood /. A. Kinnear Brown 173 The Mtoko Quintuplets F. Morley Smith and A. W. Husband 181 Muscle Relaxants in Anaesthesia 5. B a d e r ............................185 The Retroverted Uterus K. Duff ................................. 181 Effects of Certain Diseases on Population M. G e lfa n d ....................... 181 African Leishmaniasis B. K irk ..............

Use of Muscle Relaxants in Patients Without Kidney Disease

This article has no abstract

Muscle relaxants and antispasticity agents.

Muscle relaxants make up a heterogeneous group of agents and can have a clinically significant role in the treatment of chronic muscle pain. These medications are not without possible serious side effects; hence, care should be taken in deciding on their appropriateness and ongoing monitoring performed, if prescribed.